The FDA announced on March 5, 2015, that Hospira Inc. is recalling 9,912 VisIV flex containers of 0.9% Sodium Chloride Injection due to the presence of particulate matter, specifically human hair. The agency classified this as a Class I recall.
How to tell if you have it
- Brand: Hospira
- Product: 0.9% Sodium Chloride Injection, USP, 250 mL
- Container Type: VisIV Container
- NDC: 0409-7983-25
- Lot #: 45-110-C6
- Expiration Date: 03/01/16
The hazard
The recall addresses the confirmed finding of human hair floating in the IV solution. The FDA classified this as a Class I recall, indicating a high risk of adverse health consequences.
Context
GovInfoNow's records show Hospira Inc. has had 108 other recalls since April 5, 2012. On April 21, 2017, the company recalled Infant Dextrose Injection due to human hair particulates found in syringes. Other recent recalls of similar products include Fresenius Kabi Lidocaine HCl Injection (July 16, 2026) and B. Braun Medical 100mL Sodium Chloride Injection (August 19, 2026).